In silico prediction of telomerase reverse transcriptase inhibitors using modified retinol for the treatment of arsenical cancer

Retinol molecule was modified to predict the inhibitors of telomerase reverse transcriptase for the treatment of arsenical cancer through in silico study. Telomerase activity is expressed in the cancerous conditions which can be the target for anticancer activity by inhibiting telomerase reverse tra...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Kipchu Tshering, Mir Misbahuddin
Formato: Artigo
Idioma:Inglês
Publicado: Bangabandhu Sheikh Mujib Medical University 2016-09-01
Series:Bangabandhu Sheikh Mujib Medical University Journal
Assuntos:
Arsenic
Cancer
In silico
Molecular docking
Retinol
Telomerase reverse transcriptase
Acceso en liña:https://www.banglajol.info/index.php/BSMMUJ/article/view/29650
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares